{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T05:40:56Z","timestamp":1700804456475},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T00:00:00Z","timestamp":1473724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T00:00:00Z","timestamp":1473724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>G protein-coupled receptor kinase 5 (GRK5) is a regulator of cardiac performance and a potential therapeutic target in heart failure in the adult. Additionally, we have previously classified GRK5 as a determinant of left-right asymmetry and proper heart development using zebrafish. We thus aimed to identify GRK5 variants of functional significance by analysing 187 individuals with laterality defects (heterotaxy) that were associated with a congenital heart defect (CHD). Using Sanger sequencing we identified two moderately frequent variants in GRK5 with minor allele frequencies &lt;10%, and seven very rare polymorphisms with minor allele frequencies &lt;1%, two of which are novel variants. Given their evolutionarily conserved position in zebrafish, in-depth functional characterisation of four variants (p.Q41L, p.G298S, p.R304C and p.T425M) was performed. We tested the effects of these variants on normal subcellular localisation and the ability to desensitise receptor signalling as well as their ability to correct the left-right asymmetry defect upon Grk5l knockdown in zebrafish. While p.Q41L, p.R304C and p.T425M responded normally in the first two aspects, neither p.Q41L nor p.R304C were capable of rescuing the lateralisation phenotype. The fourth variant, p.G298S was identified as a complete loss-of-function variant in all assays and provides insight into the functions of GRK5.<\/jats:p>","DOI":"10.1038\/srep33231","type":"journal-article","created":{"date-parts":[[2016,9,13]],"date-time":"2016-09-13T09:56:01Z","timestamp":1473760561000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The analysis of heterotaxy patients reveals new loss-of-function variants of GRK5"],"prefix":"10.1038","volume":"6","author":[{"given":"Davor","family":"Lessel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tariq","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Casar Tena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Moepps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin D.","family":"Burkhalter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc-Phillip","family":"Hitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Okan","family":"Toka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Rentzsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adelheid","family":"Schalinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike M. M.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Kubisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie M.","family":"Ware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Philipp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,13]]},"reference":[{"key":"BFsrep33231_CR1","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/00125817-200005000-00002","volume":"2","author":"AE Lin","year":"2000","unstructured":"Lin, A. E., Ticho, B. S., Houde, K., Westgate, M. N. & Holmes, L. B. Heterotaxy: associated conditions and hospital-based prevalence in newborns. Genet Med 2, 157\u2013172, doi: 10.109700125817-200005000-00002 (2000).","journal-title":"Genet Med"},{"key":"BFsrep33231_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/boc.201400094","volume":"107","author":"T Casar Tena","year":"2015","unstructured":"Casar Tena, T., Burkhalter, M. D. & Philipp, M. Left-right asymmetry in the light of TOR: An update on what we know so far. Biol Cell 107, 306\u2013318, doi: 10.1111\/boc.201400094 (2015).","journal-title":"Biol Cell"},{"key":"BFsrep33231_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ydbio.2005.07.038","volume":"288","author":"AF Ramsdell","year":"2005","unstructured":"Ramsdell, A. F. Left-right asymmetry and congenital cardiac defects: getting to the heart of the matter in vertebrate left-right axis determination. Dev Biol 288, 1\u201320, doi: 10.1016\/j.ydbio.2005.07.038 (2005).","journal-title":"Dev Biol"},{"key":"BFsrep33231_CR4","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.2741\/3898","volume":"16","author":"ZM Huang","year":"2011","unstructured":"Huang, Z. M., Gold, J. I. & Koch, W. J. G protein-coupled receptor kinases in normal and failing myocardium. Front Biosci (Landmark Ed) 16, 3047\u20133060 (2011).","journal-title":"Front Biosci (Landmark Ed)"},{"key":"BFsrep33231_CR5","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/nm1750","volume":"14","author":"SB Liggett","year":"2008","unstructured":"Liggett, S. B. et al. A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat Med 14, 510\u2013517, doi: 10.1038\/nm1750 (2008).","journal-title":"Nat Med"},{"key":"BFsrep33231_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1097\/FPC.0b013e328341e911","volume":"21","author":"MT Lobmeyer","year":"2011","unstructured":"Lobmeyer, M. T. et al. Polymorphisms in genes coding for GRK2 and GRK5 and response differences in antihypertensive-treated patients. Pharmacogenet Genomics 21, 42\u201349, doi: 10.1097\/FPC.0b013e328341e911 (2011).","journal-title":"Pharmacogenet Genomics"},{"key":"BFsrep33231_CR7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2459\/JCM.0000000000000120","volume":"16","author":"G Novo","year":"2014","unstructured":"Novo, G. et al. G-protein-coupled receptor kinase 5 polymorphism and Takotsubo cardiomyopathy. J Cardiovasc Med (Hagerstown) 16, 639\u2013643, doi: 10.2459\/JCM.0000000000000120 (2014).","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"BFsrep33231_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/eurjhf\/hfp173","volume":"12","author":"L Spinelli","year":"2010","unstructured":"Spinelli, L. et al. L41Q polymorphism of the G protein coupled receptor kinase 5 is associated with left ventricular apical ballooning syndrome. Eur J Heart Fail 12, 13\u201316, doi: 10.1093\/eurjhf\/hfp173 (2010).","journal-title":"Eur J Heart Fail"},{"key":"BFsrep33231_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1161\/CIRCGENETICS.113.000451","volume":"7","author":"MD Kertai","year":"2014","unstructured":"Kertai, M. D. et al. G protein-coupled receptor kinase 5 gene polymorphisms are associated with postoperative atrial fibrillation after coronary artery bypass grafting in patients receiving beta-blockers. Circ Cardiovasc Genet 7, 625\u2013633, doi: 10.1161\/CIRCGENETICS.113.000451 (2014).","journal-title":"Circ Cardiovasc Genet"},{"key":"BFsrep33231_CR10","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.celrep.2013.07.036","volume":"4","author":"MD Burkhalter","year":"2013","unstructured":"Burkhalter, M. D., Fralish, G. B., Premont, R. T., Caron, M. G. & Philipp, M. Grk5l Controls Heart Development by Limiting mTOR Signaling during Symmetry Breaking. Cell Rep 4, 625\u2013632, doi: 10.1016\/j.celrep.2013.07.036 (2013).","journal-title":"Cell Rep"},{"key":"BFsrep33231_CR11","doi-asserted-by":"publisher","first-page":"26119","DOI":"10.1074\/jbc.M114.551952","volume":"289","author":"M Philipp","year":"2014","unstructured":"Philipp, M., Berger, I. M., Just, S. & Caron, M. G. Overlapping and opposing functions of G protein-coupled receptor kinase 2 (GRK2) and GRK5 during heart development. J Biol Chem 289, 26119\u201326130, doi: 10.1074\/jbc.M114.551952 (2014).","journal-title":"J Biol Chem"},{"key":"BFsrep33231_CR12","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat Methods 7, 248\u2013249, doi: 10.1038\/nmeth0410-248 (2010).","journal-title":"Nat Methods"},{"key":"BFsrep33231_CR13","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 4, 1073\u20131081, doi: 10.1038\/nprot.2009.86 (2009).","journal-title":"Nat Protoc"},{"key":"BFsrep33231_CR14","first-page":"319","volume":"51","author":"NJ Freedman","year":"1996","unstructured":"Freedman, N. J. & Lefkowitz, R. J. Desensitization of G protein-coupled receptors. Recent Prog Horm Res 51, 319\u2013351; discussion 352\u2013313 (1996).","journal-title":"Recent Prog Horm Res"},{"key":"BFsrep33231_CR15","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/onc.2014.37","volume":"34","author":"MC Buss","year":"2015","unstructured":"Buss, M. C. et al. The WIP1 oncogene promotes progression and invasion of aggressive medulloblastoma variants. Oncogene 34, 1126\u20131140, doi: 10.1038\/onc.2014.37 (2015).","journal-title":"Oncogene"},{"key":"BFsrep33231_CR16","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/msb.2012.22","volume":"8","author":"D Heitzler","year":"2012","unstructured":"Heitzler, D. et al. Competing G protein-coupled receptor kinases balance G protein and beta-arrestin signaling. Mol Syst Biol 8, 590, doi: 10.1038\/msb.2012.22 (2012).","journal-title":"Mol Syst Biol"},{"key":"BFsrep33231_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.imbio.2005.12.003","volume":"211","author":"E Palmesino","year":"2006","unstructured":"Palmesino, E., Moepps, B., Gierschik, P. & Thelen, M. Differences in CXCR4-mediated signaling in B cells. Immunobiology 211, 377\u2013389, doi: 10.1016\/j.imbio.2005.12.003 (2006).","journal-title":"Immunobiology"},{"key":"BFsrep33231_CR18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1189\/jlb.2MA0815-386R","volume":"99","author":"P Vatter","year":"2016","unstructured":"Vatter, P., Schuhholz, J., Koenig, C., Pfreimer, M. & Moepps, B. Ligand-dependent serum response factor activation by the human CC chemokine receptors CCR2a and CCR2b is mediated by G proteins of the Gq family. J Leukoc Biol 99, 979\u2013991, doi: 10.1189\/jlb.2MA0815-386R (2016).","journal-title":"J Leukoc Biol"},{"key":"BFsrep33231_CR19","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.tips.2005.09.007","volume":"26","author":"E Kostenis","year":"2005","unstructured":"Kostenis, E., Waelbroeck, M. & Milligan, G. Techniques: promiscuous Galpha proteins in basic research and drug discovery. Trends Pharmacol Sci 26, 595\u2013602, doi: 10.1016\/j.tips.2005.09.007 (2005).","journal-title":"Trends Pharmacol Sci"},{"key":"BFsrep33231_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0165-6147(99)01320-6","volume":"20","author":"G Milligan","year":"1999","unstructured":"Milligan, G. & Rees, S. Chimaeric G alpha proteins: their potential use in drug discovery. Trends Pharmacol Sci 20, 118\u2013124 (1999).","journal-title":"Trends Pharmacol Sci"},{"key":"BFsrep33231_CR21","doi-asserted-by":"publisher","first-page":"27130","DOI":"10.1074\/jbc.M204715200","volume":"277","author":"H Chikumi","year":"2002","unstructured":"Chikumi, H., Vazquez-Prado, J., Servitja, J. M., Miyazaki, H. & Gutkind, J. S. Potent activation of RhoA by Galpha q and Gq-coupled receptors. J Biol Chem 277, 27130\u201327134, doi: 10.1074\/jbc.M204715200 (2002).","journal-title":"J Biol Chem"},{"key":"BFsrep33231_CR22","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/S0092-8674(05)80020-0","volume":"81","author":"CS Hill","year":"1995","unstructured":"Hill, C. S., Wynne, J. & Treisman, R. The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF. Cell 81, 1159\u20131170 (1995).","journal-title":"Cell"},{"key":"BFsrep33231_CR23","doi-asserted-by":"publisher","first-page":"27118","DOI":"10.1074\/jbc.273.42.27118","volume":"273","author":"J Mao","year":"1998","unstructured":"Mao, J., Yuan, H., Xie, W., Simon, M. I. & Wu, D. Specific involvement of G proteins in regulation of serum response factor-mediated gene transcription by different receptors. J Biol Chem 273, 27118\u201327123 (1998).","journal-title":"J Biol Chem"},{"key":"BFsrep33231_CR24","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/FPC.0b013e32830967e9","volume":"18","author":"WC Wang","year":"2008","unstructured":"Wang, W. C., Mihlbachler, K. A., Bleecker, E. R., Weiss, S. T. & Liggett, S. B. A polymorphism of G-protein coupled receptor kinase5 alters agonist-promoted desensitization of beta2-adrenergic receptors. Pharmacogenet Genomics 18, 729\u2013732, doi: 10.1097\/FPC.0b013e32830967e9 (2008).","journal-title":"Pharmacogenet Genomics"},{"key":"BFsrep33231_CR25","doi-asserted-by":"publisher","first-page":"17989","DOI":"10.1074\/jbc.M310738200","volume":"279","author":"MM Thiyagarajan","year":"2004","unstructured":"Thiyagarajan, M. M. et al. A predicted amphipathic helix mediates plasma membrane localization of GRK5. J Biol Chem 279, 17989\u201317995, doi: 10.1074\/jbc.M310738200 (2004).","journal-title":"J Biol Chem"},{"key":"BFsrep33231_CR26","doi-asserted-by":"publisher","first-page":"20649","DOI":"10.1074\/jbc.M115.647370","volume":"290","author":"KT Homan","year":"2015","unstructured":"Homan, K. T. et al. Crystal Structure of G Protein-Coupled Receptor Kinase 5 in Complex with a Rationally Designed Inhibitor. J Biol Chem 290, 20649\u201320659, doi: 10.1074\/jbc.M115.647370 (2015).","journal-title":"J Biol Chem"},{"key":"BFsrep33231_CR27","doi-asserted-by":"publisher","first-page":"20629","DOI":"10.1074\/jbc.M115.647297","volume":"290","author":"KE Komolov","year":"2015","unstructured":"Komolov, K. E., Bhardwaj, A. & Benovic, J. L. Atomic Structure of G Protein-Coupled Receptor Kinase 5 (GRK5) Reveals Distinct Structural Features Novel for GRKs. J Biol Chem 290, 20629\u201320647, doi: 10.1074\/jbc.M115.647297 (2015).","journal-title":"J Biol Chem"},{"key":"BFsrep33231_CR28","doi-asserted-by":"publisher","first-page":"2303","DOI":"10.1242\/dev.00436","volume":"130","author":"S Long","year":"2003","unstructured":"Long, S., Ahmad, N. & Rebagliati, M. The zebrafish nodal-related gene southpaw is required for visceral and diencephalic left-right asymmetry. Development 130, 2303\u20132316 (2003).","journal-title":"Development"},{"key":"BFsrep33231_CR29","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1161\/CIRCULATIONAHA.110.947002","volume":"122","author":"SM Gilboa","year":"2010","unstructured":"Gilboa, S. M., Salemi, J. L., Nembhard, W. N., Fixler, D. E. & Correa, A. Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation 122, 2254\u20132263, doi: 10.1161\/CIRCULATIONAHA.110.947002 (2010).","journal-title":"Circulation"},{"key":"BFsrep33231_CR30","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/ng0197-30","volume":"15","author":"CT Basson","year":"1997","unstructured":"Basson, C. T. et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet 15, 30\u201335, doi: 10.1038\/ng0197-30 (1997).","journal-title":"Nat Genet"},{"key":"BFsrep33231_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1126\/science.281.5373.108","volume":"281","author":"JJ Schott","year":"1998","unstructured":"Schott, J. J. et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281, 108\u2013111 (1998).","journal-title":"Science"},{"key":"BFsrep33231_CR32","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.clp.2015.02.009","volume":"42","author":"JR Cowan","year":"2015","unstructured":"Cowan, J. R. & Ware, S. M. Genetics and genetic testing in congenital heart disease. Clin Perinatol 42, 373\u2013393, ix, doi: 10.1016\/j.clp.2015.02.009 (2015).","journal-title":"Clin Perinatol"},{"key":"BFsrep33231_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2174\/157340310791162703","volume":"6","author":"AA Richards","year":"2010","unstructured":"Richards, A. A. & Garg, V. Genetics of congenital heart disease. Curr Cardiol Rev 6, 91\u201397, doi: 10.2174\/157340310791162703 (2010).","journal-title":"Curr Cardiol Rev"},{"key":"BFsrep33231_CR34","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1253\/circj.CJ-12-0957","volume":"76","author":"I Shiraishi","year":"2012","unstructured":"Shiraishi, I. & Ichikawa, H. Human heterotaxy syndrome - from molecular genetics to clinical features, management, and prognosis. Circ J 76, 2066\u20132075 (2012).","journal-title":"Circ J"},{"key":"BFsrep33231_CR35","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1161\/CIRCULATIONAHA.109.857987","volume":"120","author":"N Oyen","year":"2009","unstructured":"Oyen, N. et al. Recurrence of congenital heart defects in families. Circulation 120, 295\u2013301, doi: 10.1161\/CIRCULATIONAHA.109.857987 (2009).","journal-title":"Circulation"},{"key":"BFsrep33231_CR36","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1073\/pnas.1019645108","volume":"108","author":"KA Fakhro","year":"2011","unstructured":"Fakhro, K. A. et al. Rare copy number variations in congenital heart disease patients identify unique genes in left-right patterning. Proc Natl Acad Sci USA 108, 2915\u20132920, doi: 10.1073\/pnas.1019645108 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep33231_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s40142-014-0049-3","volume":"2","author":"Ja Lander","year":"2014","unstructured":"Lander, J. a. & Ware, S. M. Copy number variation in congenital heart defects. Curr Genet Med Rep 2, 168\u2013178 (2014).","journal-title":"Curr Genet Med Rep"},{"key":"BFsrep33231_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ajhg.2008.05.012","volume":"83","author":"E Roessler","year":"2008","unstructured":"Roessler, E. et al. Reduced NODAL signaling strength via mutation of several pathway members including FOXH1 is linked to human heart defects and holoprosencephaly. Am J Hum Genet 83, 18\u201329, doi: 10.1016\/j.ajhg.2008.05.012 (2008).","journal-title":"Am J Hum Genet"},{"key":"BFsrep33231_CR39","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/tera.10099","volume":"66","author":"KS Kuehl","year":"2002","unstructured":"Kuehl, K. S. & Loffredo, C. Risk factors for heart disease associated with abnormal sidedness. Teratology 66, 242\u2013248, doi: 10.1002\/tera.10099 (2002).","journal-title":"Teratology"},{"key":"BFsrep33231_CR40","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1161\/CIRCGENETICS.112.963579","volume":"5","author":"KL McBride","year":"2012","unstructured":"McBride, K. L. & Ware, S. M. Modifying Mendel: approaches for identification of susceptibility alleles for human cardiovascular malformations. Circ Cardiovasc Genet 5, 274\u2013276, doi: 10.1161\/CIRCGENETICS.112.963579 (2012).","journal-title":"Circ Cardiovasc Genet"},{"key":"BFsrep33231_CR41","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/363274a0","volume":"363","author":"BR Conklin","year":"1993","unstructured":"Conklin, B. R., Farfel, Z., Lustig, K. D., Julius, D. & Bourne, H. R. Substitution of three amino acids switches receptor specificity of Gq alpha to that of Gi alpha. Nature 363, 274\u2013276, doi: 10.1038\/363274a0 (1993).","journal-title":"Nature"},{"key":"BFsrep33231_CR42","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1016\/j.cellsig.2008.04.010","volume":"20","author":"B Moepps","year":"2008","unstructured":"Moepps, B. et al. Constitutive serum response factor activation by the viral chemokine receptor homologue pUS28 is differentially regulated by Galpha(q\/11) and Galpha(16). Cell Signal 20, 1528\u20131537, doi: 10.1016\/j.cellsig.2008.04.010 (2008).","journal-title":"Cell Signal"},{"key":"BFsrep33231_CR43","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1210\/mend.11.9.9975","volume":"11","author":"L Hein","year":"1997","unstructured":"Hein, L., Meinel, L., Pratt, R. E., Dzau, V. J. & Kobilka, B. K. Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand. Mol Endocrinol 11, 1266\u20131277, doi: 10.1210\/mend.11.9.9975 (1997).","journal-title":"Mol Endocrinol"},{"key":"BFsrep33231_CR44","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1021\/bi501061h","volume":"54","author":"M Burczyk","year":"2015","unstructured":"Burczyk, M. et al. Phenotypic regulation of the sphingosine 1-phosphate receptor miles apart by g protein-coupled receptor kinase 2. Biochemistry 54, 765\u2013775, doi: 10.1021\/bi501061h (2015).","journal-title":"Biochemistry"},{"key":"BFsrep33231_CR45","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1021\/ac200213b","volume":"83","author":"EJ Soderblom","year":"2011","unstructured":"Soderblom, E. J., Philipp, M., Thompson, J. W., Caron, M. G. & Moseley, M. A. Quantitative label-free phosphoproteomics strategy for multifaceted experimental designs. Anal Chem 83, 3758\u20133764, doi: 10.1021\/ac200213b (2011).","journal-title":"Anal Chem"},{"key":"BFsrep33231_CR46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nprot.2007.514","volume":"3","author":"C Thisse","year":"2008","unstructured":"Thisse, C. & Thisse, B. High-resolution in situ hybridization to whole-mount zebrafish embryos. Nat Protoc 3, 59\u201369, doi: 10.1038\/nprot.2007.514 (2008).","journal-title":"Nat Protoc"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep33231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep33231","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep33231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:25:46Z","timestamp":1672878346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep33231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,13]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,16]]}},"alternative-id":["BFsrep33231"],"URL":"https:\/\/doi.org\/10.1038\/srep33231","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,13]]},"assertion":[{"value":"25 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33231"}}